相关实验视频

Updated: Feb 26, 2026

A Syngeneic Mouse B-Cell Lymphoma Model for Pre-Clinical Evaluation of CD19 CAR T Cells
12:16

A Syngeneic Mouse B-Cell Lymphoma Model for Pre-Clinical Evaluation of CD19 CAR T Cells

Published on: October 16, 2018

15.6K

CD19 CAR T细胞治疗对淋巴瘤患者病原体特异抗体标位的影响

Hayley Foy-Stones1,2, Nicola Gardiner1,3, Ellen Walsh2

  • 1Cryobiology Laboratory Stem Cell Facility, St. James's Hospital, Dublin, Ireland.

Transplant infectious disease : an official journal of the Transplantation Society
|February 25, 2026
PubMed
概括

化学抗原受体 (CAR) 对B细胞恶性瘤的T细胞疗法在很大程度上保留了幽默免疫力. 病原体特异性IgG标位保持稳定,肺炎球菌和Hib IgG略有下降,这表明在例行再接种疫苗时要仔细监测.

关键词:
在CAR T细胞疗法中.CD19 CD19 CD19 CD19 CD19 CD19 CD19 CD19 CD19 CD19 CD19 CD19 CD19 CD19 CD19甲型B型的Hemophilus influenzae病毒的发生.淋巴瘤淋巴瘤是什么麻疹病毒的病毒麻疹病毒病毒.病原体抗体标位 病原体抗体标位肺炎球菌的囊型多糖化物红疹病毒是红疹病毒.结节炎毒素毒素是什么疹病毒 (varicella zoster virus) 是一种病毒.

更多相关视频

Dynamic Imaging of Chimeric Antigen Receptor T Cells with [18F]Tetrafluoroborate Positron Emission Tomography/Computed Tomography09:34

Dynamic Imaging of Chimeric Antigen Receptor T Cells with [18F]Tetrafluoroborate Positron Emission Tomography/Computed Tomography

Published on: February 17, 2022

3.9K
Manufacturing Chimeric Antigen Receptor CAR T Cells for Adoptive Immunotherapy06:51

Manufacturing Chimeric Antigen Receptor CAR T Cells for Adoptive Immunotherapy

Published on: December 17, 2019

16.0K

相关概念视频

Tumor Immunotherapy01:27

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
2.1K